Literature DB >> 16791845

Bladder augmentation for the treatment of chronic tuberculous cystitis. Clinical and urodynamic evaluation of 25 patients after long term follow-up.

André Avarese de Figueiredo1, Antônio Marmo Lucon, Miguel Srougi.   

Abstract

AIMS: Clinical and urodynamic evaluation of the late outcome of 25 patients with chronic tuberculous cystitis who underwent bladder augmentation. PATIENTS AND METHODS: Twenty men and five women with median age of 40 years were evaluated. The tubularized ileocecal segment was used in 8 cases, the detubularized sigmoid in 13, and the tubularized sigmoid in 4. Patients underwent a postoperative clinical and urodynamic evaluation. Miccional diurnal frequency of more than 2 hr together with patient satisfaction as assessed by the quality of life question of the ICSmaleSF questionnaire was considered a good result.
RESULTS: The average postoperative follow-up was of 11.1 +/- 9.1 (1 to 36) years. A good result was seen in 80% of the patients. Bad results occurred statistically in the cases using tubularized sigmoid and in patients with prostatitis. Patients with good results showed augmented bladders with normal sensation (P = 0.03) and greater capacity (P < 0.01) and compliance (P < 0.01) than did those with bad results. There was no statistically significant difference in the frequency of involuntary contractions (P = 0.27) but in the good result patients, the contractions started with greater bladder filling volume (P = 0.02).
CONCLUSIONS: The sigmoid should be detubularized but the ileocecal segment may be used in its original tubularized form to augment the bladder with chronic tuberculous cystitis. Augmented bladder with capacity of more than 250 ml, good compliance, and normal sensation are necessary for diurnal frequency of more than 2 hr. The presence of involuntary contractions does not lead to a decrease in the diurnal frequency.

Entities:  

Mesh:

Year:  2006        PMID: 16791845     DOI: 10.1002/nau.20264

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  7 in total

1.  Reconstructive surgery for tuberculous contracted bladder: experience of a center in northern India.

Authors:  Vishwajeet Singh; Rahul Janak Sinha; S N Sankhwar; Seema Mehrotra Sinha
Journal:  Int Urol Nephrol       Date:  2010-08-03       Impact factor: 2.370

2.  All in the Stream.

Authors:  Benjamin Mba; Brian P Lucas; Nathan Houchens; Jennifer Marie Seares; Udit Joshi
Journal:  J Hosp Med       Date:  2019-09-18       Impact factor: 2.960

3.  Urogenital tuberculosis: update and review of 8961 cases from the world literature.

Authors:  André A Figueiredo; Antônio M Lucon
Journal:  Rev Urol       Date:  2008

4.  Urogenital tuberculosis in immunocompromised patients.

Authors:  Andre Avarese Figueiredo; Antonio Marmo Lucon; Renato Falci Júnior; Diego Shiguemi Ikejiri; William Carlos Nahas; Miguel Srougi
Journal:  Int Urol Nephrol       Date:  2008-07-22       Impact factor: 2.370

5.  "Spiral-Cap" ileocystoplasty for bladder augmentation and ureteric reimplant.

Authors:  S Ajit Sawant; Ashwin Sunil Tamhankar; Vikash Kumar; W Pawar Prakash; V Kasat Gaurav; Sumit Bansal
Journal:  Urol Ann       Date:  2016 Oct-Dec

Review 6.  Measuring health-related quality of life in tuberculosis: a systematic review.

Authors:  Na Guo; Fawziah Marra; Carlo A Marra
Journal:  Health Qual Life Outcomes       Date:  2009-02-18       Impact factor: 3.186

7.  Augmentation cystoplasty: Contemporary indications, techniques and complications.

Authors:  Rajan Veeratterapillay; Andrew C Thorpe; Chris Harding
Journal:  Indian J Urol       Date:  2013-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.